MolMap resolves functional chromatin responses to small-molecule perturbation
En palabras de los autores
Small molecules can alter chromatin through protein-, DNA- and physicochemical interactions, yet current approaches do not directly resolve where these perturbations produce an immediate functional chromatin response in native nuclear environments. Here we present MolMap (chromatin-small Molecule Mapping), a sequencing-based method that profiles genome-wide chromatin responses to chemically unmodified compounds in isolated, non-crosslinked nuclei. Rather than measuring ligand binding, protein occupancy or downstream gene expression, MolMap identifies genomic regions where small-molecule exposure produces an immediate functional chromatin response. By quantifying changes in Tn5 accessibility and local chromatin organization in native nuclei, MolMap captures locus-specific and dose-dependent effects while separating early chromatin responses from downstream cellular adaptation. Across metabolites, protein-targeting compounds, a DNA-binding drug and a physicochemical chromatin modulator, MolMap resolved compound-specific and mechanistically distinct responses. Comparison with live-cell ATAC-seq showed that MolMap captures early chromatin responses before broader cellular adaptation. In leukemia models, MolMap revealed a coordinated chromatin response in drug-sensitive cells that was strongly attenuated in resistant models. MolMap therefore provides a native framework for bridging the precision of biochemical perturbation assays with the breadth of genome-wide profiling, extending classical chromatin biochemistry into a genomic setting.
Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.